Tumor-infiltrating lymphocytes (TILs) comprise diverse populations, including CD8+ T cells, CD4+ T cells, B cells, NK cells, and regulatory T cells (Tregs), all exerting significant impacts on tumor development and progression [67]. This evidence concerns the gene CD8A and neoplasm.